Malignant mesothelioma treated with immune checkpoint inhibitors with or without cancer vaccine (the NIPU-study)
– a phase II randomised clinical and translational trial
- EudraCT number: 2019-002721-30
- Clinicaltrials.gov: NCT04300244
| Background/study objectives |
| Study design |
| Collaborative partners |
| Update/publications |